A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Cleveland Clinic Lerner College of Medicine · Case Western Reserve University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
120
total citations
- FWCI
- 26.07
- Percentile
- 100%
- References
- 83
Citations per year
Authors
19- MFMarc FerrellCorresponding
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
- ZWZeneng Wang
Cleveland Clinic Lerner College of Medicine
- JTJames T. Anderson
Cleveland Clinic Lerner College of Medicine
- XSXinmin S. Li
Cleveland Clinic Lerner College of Medicine
- MWMarco Witkowski
Cleveland Clinic Lerner College of Medicine, Deutsches Herzzentrum der Charité, Charité - Universitätsmedizin Berlin
Topics & keywords
Topics
Keywords
- Niacin
- Hazard ratio
- Medicine
- Internal medicine
- Mace
- Prospective cohort study
- Cohort
- Confidence interval
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- OOOffice of Dietary SupplementsAwards: R01HL103866, P01HL147823
- SSanofi
- SCSouthern California Environmental Health Sciences CenterAward: P30ES007048
- DFDeutsche ForschungsgemeinschaftAward: WI 5229/1-1
- BIBerlin Institute of Health
- NINational Institutes of HealthAwards: P01 HL147823, T32 GM007250, P30ES007048, R01HL103866, R01 HL133169, P01HL147823, R01 HL148110, GM007250, R01HL133169, R01 HL103866, T32 HL134622
- SDSanofi-Aventis Deutschland
- NHNational Heart, Lung, and Blood InstituteAwards: R01HL133169, P01HL147823, R01HL168493, R01HL148110, R01HL103866, U54HL170326